Compare CSPI & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSPI | OKYO |
|---|---|---|
| Founded | 1968 | 2007 |
| Country | United States | United Kingdom |
| Employees | 123 | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.5M | 83.4M |
| IPO Year | 1994 | 2021 |
| Metric | CSPI | OKYO |
|---|---|---|
| Price | $9.75 | $1.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.33 |
| AVG Volume (30 Days) | 9.9K | ★ 41.6K |
| Earning Date | 05-08-2026 | 07-18-2025 |
| Dividend Yield | ★ 1.15% | N/A |
| EPS Growth | ★ 75.00 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $58,730,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $233.13 | ★ N/A |
| Revenue Growth | ★ 6.36 | N/A |
| 52 Week Low | $7.55 | $1.44 |
| 52 Week High | $15.49 | $3.35 |
| Indicator | CSPI | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 57.65 | 55.21 |
| Support Level | $9.72 | $1.48 |
| Resistance Level | $10.59 | $1.73 |
| Average True Range (ATR) | 0.58 | 0.06 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 65.32 | 65.57 |
CSP Inc develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments, namely Technology Solutions, where the company focuses on value-added reseller integrated solutions, including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company designs, manufactures, and delivers products and services to customers that require specialized cybersecurity services, networking, and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates the majority of its revenue from the Americas.
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.